DexCom (DXCM)
(Real Time Quote from BATS)
$70.37 USD
+0.75 (1.08%)
Updated Aug 30, 2024 10:18 AM ET
4-Sell of 5 4
D Value B Growth B Momentum C VGM
DexCom (DXCM) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$96.18 | $130.00 | $75.00 | 38.15% |
Price Target
Based on short-term price targets offered by 22 analysts, the average price target for DexCom comes to $96.18. The forecasts range from a low of $75.00 to a high of $130.00. The average price target represents an increase of 38.15% from the last closing price of $69.62.
Analyst Price Targets (22)
Broker Rating
DexCom currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 22 brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on 22 recommendations.
Of the 22 recommendations deriving the current ABR, 16 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 72.73% and 4.55% of all recommendations. A month ago, Strong Buy made up 72.73%, while Buy represented 4.55%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/DXCM.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 16 | 16 | 16 | 18 | 18 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 5 | 5 | 5 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.50 | 1.50 | 1.32 | 1.32 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/29/2024 | Cowen & Co. | Joshua T Jennings | Strong Buy | Strong Buy |
7/26/2024 | BTIG | Marie Thibault | Strong Buy | Strong Buy |
7/26/2024 | William Blair | Margaret Kaczor | Strong Buy | Strong Buy |
7/26/2024 | Robert W. Baird & Co. | Jeffrey D Johnson | Strong Buy | Hold |
7/26/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/26/2024 | UBS | Danielle Antalffy | Strong Buy | Strong Buy |
7/26/2024 | Raymond James | Jayson T Bedford | Strong Buy | Strong Buy |
7/26/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
7/26/2024 | Canaccord Genuity | William J Plovanic | Strong Buy | Strong Buy |
7/25/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/25/2024 | Piper Sandler | Matthew O'Brien | Strong Buy | Strong Buy |
6/24/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/20/2024 | Wells Fargo Securities | Lawrence H Biegelsen | Strong Buy | Strong Buy |
5/30/2024 | Atlantic Equities | Issie Kirby | Not Available | Hold |
5/28/2024 | SVB Securities | Michael Kratky | Strong Buy | Strong Buy |
5/6/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/1/2024 | Not Identified | Not Identified | Hold | Hold |
4/3/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
10/27/2023 | Not Identified | Not Identified | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 22 |
Average Target Price | $96.18 |
LT Growth Rate | 19.10% |
Industry | Medical - Instruments |
Industry Rank by ABR | 77 of 253 |
Current Quarter EPS Est: | 0.44 |